Rhythm Pharmaceuticals Ownership | Who Owns Rhythm Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Rhythm Pharmaceuticals Ownership Summary


Rhythm Pharmaceuticals is owned by 104.47% institutional investors, 0.65% insiders. Blackrock is the largest institutional shareholder, holding 11.21% of RYTM shares. PRIMECAP Odyssey Aggressive Growth is the top mutual fund, with 4.68% of its assets in Rhythm Pharmaceuticals shares.

RYTM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRhythm Pharmaceuticals104.47%0.65%-5.11%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock6.74M11.21%$276.82M
Blackrock funding, inc. /de6.27M9.84%$396.05M
Baker bros. advisors lp5.60M8.80%$354.15M
Ra capital management5.56M8.73%$351.42M
Primecap management co/ca/4.88M7.66%$308.24M
Vanguard group3.44M5.62%$192.72M
Nea management company2.91M4.57%$183.88M
Perceptive advisors2.42M3.80%$152.81M
State street2.00M3.33%$82.28M
Goldman sachs group1.81M2.96%$101.45M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Checkpoint capital727.98K20.74%$40.75M
Nea management company2.91M13.84%$183.88M
Ra capital management5.56M5.92%$351.42M
Perceptive advisors2.42M5.67%$152.81M
Opaleye management500.00K4.90%$27.99M
Nan fung group49.12K4.89%$3.10M
Silverarc capital management400.77K4.67%$25.32M
Stempoint capital lp176.75K3.58%$11.17M
Baker bros. advisors lp5.60M3.44%$354.15M
Rock springs capital management lp861.15K3.39%$54.42M

Top Buyers

HolderShares% AssetsChange
Polar capital1.25M0.41%750.87K
Janus henderson group1.22M0.03%621.43K
Adage capital partners gp341.00K0.04%341.00K
Morgan stanley475.65K0.00%292.78K
Westfield capital management co lp1.63M0.43%288.38K

Top Sellers

HolderShares% AssetsChange
Goldman sachs group1.81M0.02%-2.07M
Healthcare of ontario pension plan trust fund---1.11M
State street2.00M0.00%-1.01M
Primecap management co/ca/4.88M0.24%-909.28K
Frazier life sciences management---678.76K

New Positions

HolderShares% AssetsChangeValue
Adage capital partners gp341.00K0.04%341.00K$21.55M
Norges bank205.65K0.00%205.65K$11.51M
Artisan partners limited partnership174.48K0.02%174.48K$11.03M
Nomura157.30K0.01%157.30K$6.46M
Logos global management lp130.00K0.91%130.00K$8.21M

Sold Out

HolderChange
Ifp advisors-1.00
Innealta capital-7.00
Covestor-10.00
Hexagon capital partners-11.00
Ronald blue trust-15.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025236-0.42%66,529,0344.29%1041.02%124-3.88%767.04%
Mar 31, 202523812.26%64,653,938-0.38%1020.91%13011.11%7226.32%
Dec 31, 20241975.35%58,110,291-14.09%940.78%11220.43%50-12.28%
Sep 30, 20241877.47%67,638,955-2.40%1100.83%933.33%579.62%
Jun 30, 2024174-1.14%69,303,0851.97%1150.90%902.27%52-5.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
PRIMECAP Odyssey Aggressive Growth3.09M4.68%-779.65K
Vanguard Total Stock Mkt Idx Inv2.02M3.05%-51.22K
Vanguard US Total Market Shares ETF1.92M3.03%2.33K
PRIMECAP Odyssey Growth1.53M2.32%-111.43K
iShares Russell 2000 ETF1.28M1.93%-24.36K
Polar Capital Biotech S Inc1.25M1.89%-
Federated Hermes Kaufmann Small Cap A742.00K1.12%1.93K
Federated Hermes Kaufmann Small Cap Grow742.00K1.12%1.93K
Federated Hermes Kaufmann R733.00K1.11%41.70K
Federated Hermes Kaufmann Growth733.00K1.11%41.70K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 02, 2025Shulman Joseph Chief Technical OfficerSell$1.77M
Aug 21, 2025Shulman Joseph Chief Technical OfficerSell$419.09K
Aug 12, 2025Smith Hunter C Chief Financial OfficerSell$2.37M
Aug 13, 2025Smith Hunter C Chief Financial OfficerSell$333.79K
Aug 12, 2025German Christopher Paul Corporate Controller & CAOSell$142.50K

Insider Transactions Trends


DateBuySell
2025 Q3-19
2025 Q2-16
2025 Q1-35
2024 Q4-9
2024 Q3-17

RYTM Ownership FAQ


Who Owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals shareholders are primarily institutional investors at 104.47%, followed by 0.65% insiders and -5.12% retail investors. The average institutional ownership in Rhythm Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Rhythm Pharmaceuticals falls below.

Who owns the most shares of Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals’s largest shareholders are Blackrock (6.74M shares, 11.21%), Blackrock funding, inc. /de (6.27M shares, 9.84%), and Baker bros. advisors lp (5.6M shares, 8.80%). Together, they hold 29.85% of Rhythm Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rhythm Pharmaceuticals?

Yes, BlackRock owns 11.21% of Rhythm Pharmaceuticals, totaling 6.74M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 276.82M$. In the last quarter, BlackRock increased its holdings by 212.28K shares, a 3.25% change.

Who is Rhythm Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Checkpoint capital is Rhythm Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 20.74% of its assets in 727.98K Rhythm Pharmaceuticals shares, valued at 40.75M$.

Who is the top mutual fund holder of Rhythm Pharmaceuticals shares?

PRIMECAP Odyssey Aggressive Growth is the top mutual fund holder of Rhythm Pharmaceuticals shares, with 4.68% of its total shares outstanding invested in 3.09M Rhythm Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools